Array
(
    [0] => Array
        (
            [value] => 21022
            [revision_id] => 21033
        )

    [1] => Array
        (
            [value] => 21023
            [revision_id] => 21034
        )

    [2] => Array
        (
            [value] => 21024
            [revision_id] => 21035
        )

    [3] => Array
        (
            [value] => 21025
            [revision_id] => 21036
        )

)

We care for animals.

When they are healthy, humans are healthier too. We commit to making the industry even better at improving both human and animal health.Learn more about Merial here.

horse-header-image-india

Killed Virus Vaccine

Equine influenza virus vaccine

Formula Indication Features & Benefits Dosage & Administration Presentation
Incorporates the emerging North American EIV strain, North American EIV strain and Eurasian EIV strain For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease.
  • Novel adjuvant
  • No reversion to virulence
  • Minimal vaccine site reactions
  • Using aseptic technique inoculate horses above 6 months of age, intra-muscularly with a 2 ml dose.
  • Administer a second, 2 ml dose intra-muscularly after 3-4 weeks of first vaccination, using a different injection site.
  • Administer a third, 2 mL dose after 3-4 weeks of second vaccination, intra-muscularly or by intra-nasal route
  • Revaccinate annually and prior to anticipated exposure by intra- muscular route
 Glass vial of 20 ml (10 doses)